ASK REDCHAT ANYTHING ABOUT SCORPIUS HOLDINGS INC.
Scorpius Holdings Inc. (OTCQB: SCPX)
Listen to this Section
$0.00
N/A
(
0% )
0.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ANTHIM® (obiltoxaximab)DetailsAnthrax |
Approved |
| PTX-35 (TNFRSF25)DetailsSolid tumor/s, Cancer |
Failed |
| HS-130 (OX40L)DetailsSolid tumor/s, Cancer |
Failed |
| HS-110 (gp96 + CTAs)DetailsLung cancer, Non-small cell lung carcinoma, Cancer |
Failed |
Market Data
| Open |
$0.00 |
| Previous Close |
$0.00 |
| Volume |
0.0K |
| Market Cap |
$0.09M |
| Day Range |
$0.00 - $0.00 |
| 52 Week Range |
$0.00 - $0.35 |
| Shares Outstanding |
61.14M |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
N/A |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-2,500,000.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-05-17 |
Sale |
-2500000.00 |
Wolf Jeffrey Alan |